Medevice
- Company typePrivate
- Founded2011
- HeadquartersParis, France
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Medevice does
Medevice SA is a Geneva-based private investment fund founded in 2011 that invests exclusively in early-stage MedTech and e-health companies. The firm targets seed rounds with tickets of €1M–€1.5M and participates in Series A rounds up to €4M, sourcing deals across five European markets — France, Switzerland, Belgium, Spain, and Portugal. Its portfolio spans roughly 17 companies and 9 realized exits, with disclosed holdings including KOELIS (prostate imaging), Pixyl (medical imaging AI), Gleamer (AI radiology), and BEPATIENT (digital health), reflecting a deliberate tilt toward device-plus-software MedTech.
The fund is operated by a four-person senior team led by CEO Cécile Real, alongside Partners Nicolas Lascaud and Sandra Francisco, and Venture Partner Jérôme Descheirder. The team's prior experience spans GE Healthcare, Sanofi, and KPMG, which Medevice positions as operator-led diligence and portfolio support. Medevice is a small vehicle by headcount (1–10 employees) and is not publicly listed; its revenue model follows standard venture-fund mechanics of management fees on committed capital plus carried interest on exits, with nine exits to date providing the carry track record.
Medevice maintains a specialist positioning in European medical technology, presenting at sector events such as the EANM congress and cultivating repeat deal flow through its alumni founder network. As a single-stage specialist rather than a multi-stage generalist, the fund competes on domain depth and follow-on capacity rather than scale or brand.
Medevice firmographics
Firmographics- Name
- Medevice
- Legal name
- Medevice SA
- Website
- https://medevice.eu
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Medevice industry classification
Industry- Product category
- Venture Capital - Healthcare (MedTech and e-health)
- NAICS
- Portfolio Management and Investment Advice (523940)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Equipment Financing / Leasing (Venture-backed) (FSANAIAE)
Keywords
Where Medevice is headquartered
LocationHeadquarters
- HQ city
- Paris
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
Medevice business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Investment Returns / Capital Gains: As a venture capital fund, MEDEVICE generates returns through equity investments in early-stage healthcare companies. The fund takes equity stakes in portfolio companies and realizes returns upon exits (9 exits mentioned).
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Seed/Amorçage Investment |
| Other | Multi-year contract | Series A Investment |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Medevice product offering
Product offeringCore offering
Medevice is a seed-stage venture capital fund that invests exclusively in MedTech and e-health startups in Europe. The firm deploys investment tickets of €1M to €1.5M at seed stage and up to €4M for Series A follow-ons, targeting portfolio companies that aim to reach market within three years across France, Switzerland, Belgium, Spain, and Portugal. Beyond capital, Medevice provides active operational support across R&D, patents, industrialization, regulatory/quality, sales and business development, HR, and finance.
Product overview
Medevice is a seed-stage investment fund (fonds d'investissement d'amorçage) dedicated exclusively to MedTech and e-health innovation, founded in 2011 and based in Geneva, Switzerland. The firm deploys investment tickets ranging from €1M to €1.5M at seed stage, extending up to €4M for Series A rounds, across startups in France, Switzerland, Belgium, Spain, and Portugal that target market entry within three years. Rather than offering a unified product platform, Medevice provides a portfolio of 15+ portfolio companies spanning various medtech and e-health subsectors including diagnostics, therapeutics, medical devices, and digital health solutions, supplemented by strategic and operational support services in R&D, patents, industrialization, regulatory/quality, sales, HR, and finance. The investment vehicle does not itself produce products but acts as a financial and strategic partner to early-stage companies including KOELIS, ENDODIAG, CERTIS THERAPEUTICS, DYAMEO, EMAGINA, PAIRE, TAURUS ENDOSCOPY, FLOWSTIM TECHNOLOGY, EVEON, BE PATIENT, MEDECIN DIRECT, AVALUN, ALPAO, ABOLIS, IMACTIS, PIXYL, and GLEAMER.
Differentiator
Problem solved
Functional benefit
Products and services
- Seed-Stage MedTech and E-health Investment Program Equity seed-stage investment tickets of €1M to €1.5M for innovative MedTech and e-health startups in Europe (France, Switzerland, Belgium, Spain, Portugal), targeting portfolio companies with a time-to-market of less than three years. Includes active operational support across R&D, patents, industrialization, regulatory and quality, sales and business development, HR, and finance.
- Series A Follow-On Investment Program Series A follow-on equity investments of up to €4M for portfolio MedTech and e-health companies that have progressed from seed, supporting growth, market entry, and additional round participation. Available to existing portfolio companies meeting Medevice's criteria.
Quantifiable outcome
- 9 successful exits from portfolio
- +1 more outcomes
Companies that use Medevice
Customer profileNamed customers6 records
Segments1 record
Ideal customer profiles1 record
Medevice technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Medevice partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights4 records
Medevice competitors and assessment
Company assessmentBroad incumbents
- GIMV: Belgian-listed private equity/venture capital firm with a dedicated Health & Care platform investing across MedTech and digital health. Larger incumbent providing overlap on Belgian/European MedTech deals though at broader scale.
- LBO France: French private equity firm with a healthcare-dedicated strategy (including the White Knight and Innovation Capital funds) covering MedTech and biotech. Comparable French/European footprint and healthcare sector focus.
Direct peers
- Vesalius Biocapital: European venture capital firm dedicated to healthcare, with seed-to-growth investments in MedTech and biotech. Directly comparable sector specialization and European (including Benelux/DACH) footprint.
- Sofinnova Partners: Leading European venture capital firm focused on life sciences (biopharma, MedTech, digital medicine) with deep roots in France. Comparable MedTech investment mandate and active hands-on support model across the European footprint.
- Karista (now part of Turenne Group): Paris-based venture capital firm with a dedicated Health & Digital Care strategy investing in early-stage MedTech and digital health startups across Europe. Direct sector and geography overlap with Medevice.
- Andera Partners: Paris-based private equity and venture capital firm with dedicated healthcare/life sciences strategies covering MedTech and biotech. Comparable European healthcare focus and stage range, including seed through growth.
- Forbion: Dutch-based European venture capital firm focused on life sciences and MedTech, with active hands-on support across the portfolio. Comparable MedTech/healthcare thesis with European footprint and operator-involved investing.
- Kurma Partners: Paris-based venture capital firm investing in healthcare and life sciences across Europe, with a comparable early-stage focus on therapeutics, MedTech, and digital health. Direct overlap in sector mandate, geography, and ticket sizes.
- BioMed Partners (now part of EY-Parthenon): Swiss-based healthcare venture capital firm historically investing in MedTech and biotech across Europe. Shares Swiss hub, MedTech sector focus, and active operating-partner model comparable to Medevice.
Regional players
- Capricorn Partners: Belgian venture capital firm with a dedicated Capricorn Health-tech Fund focused on early-stage MedTech and digital health. Strong geographical overlap with Medevice's Belgian deal flow and similar sector thesis.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
Medevice social profiles
Digital presenceMedevice financial estimates
Financial estimateRevenue estimate
Valuation estimate
Medevice leadership team
Management profileNumber of profiles
Profiles4 records
Medevice funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Medevice M&A and investment
M&A and investmentM&A
Investments2 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Medevice
What does Medevice do?
Medevice is a seed-stage venture capital fund that invests exclusively in MedTech and e-health startups in Europe. The firm deploys investment tickets of €1M to €1.5M at seed stage and up to €4M for Series A follow-ons, targeting portfolio companies that aim to reach market within three years across France, Switzerland, Belgium, Spain, and Portugal. Beyond capital, Medevice provides active operational support across R&D, patents, industrialization, regulatory/quality, sales and business development, HR, and finance.
Is Medevice a public or private company?
Medevice is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Medevice founded?
Medevice was founded in 2011. It employs 1 to 10 people.
Where is Medevice based?
Medevice is headquartered in Paris, France, in the Europe region.
How does Medevice make money?
One revenue line is on record: investment Returns / Capital Gains.
Who are Medevice's main competitors?
Broad incumbents on record are GIMV and LBO France. Direct peers are Vesalius Biocapital, Sofinnova Partners, Karista (now part of Turenne Group), Andera Partners, Forbion, Kurma Partners and BioMed Partners (now part of EY-Parthenon). Capricorn Partners is listed as a regional player.
Does Medevice have an API?
No public API is recorded for Medevice.
What industry is Medevice in?
Medevice's product category is Venture Capital - Healthcare (MedTech and e-health). Its primary akta.pro industry code is FSANAIAE, Equipment Financing / Leasing (Venture-backed). Its NAICS code is 523940 and its SIC code is 6282.